One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
COP27 Climate Change Conference: urgent action needed for Africa and the world: Wealthy nations must step up support for Africa and vulnerable countries in addressing past, present and future impacts of climate change
Lukoye Atwoli, Gregory E Erhabor, Aiah A Gbakima, Abraham Haileamlak, Jean-Marie Kayembe Ntumba, James Kigera, Laurie Laybourn-Langton, Bob Mash, Joy Muhia, Fhumulani Mavis Mulaudzi, David Ofori-Adjei, Friday Okonofua, Arash Rashidian, Maha El-Adawy, Siaka Sidibé, Abdelmadjid Snouber, James Tumwine, Mohammad Sahar Yassien, Paul Yonga, Lilia Zakhama, Chris Zielinski
doi : 10.1093/rheumatology/keac573
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1721–1723
The use of combination monoclonal antibody therapies in lupus—where are we now?
Joana Rua, Maria Dall’Era, David Isenberg
doi : 10.1093/rheumatology/keac482
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1724–1729
More to B: the growing evidence to inform targeting B cells in scleroderma
Silvia Laura Bosello, Edward M Vital, Francesco Del Galdo
doi : 10.1093/rheumatology/keac677
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1730–1732
How extensively should ultrasound be performed in suspected giant cell arteritis?
Wolfgang A Schmidt
doi : 10.1093/rheumatology/keac616
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1733–1735
The influence of low educational attainment on progress in rheumatoid arthritis: nature or nurture?
Marwan Bukhari
doi : 10.1093/rheumatology/keac615
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1736–1737
Which should be first: biologic DMARDs or Janus kinase inhibitors?
Tatsuya Koike
doi : 10.1093/rheumatology/keac629
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1738–1739
Assessment and diagnosis of the acute hot joint: a systematic review and meta-analysis
Mrinalini Dey, Mariam Al-Attar, Leticia Peruffo, Ashley Coope, Sizheng Steven Zhao, Stephen Duffield, Nicola Goodson
doi : 10.1093/rheumatology/keac606
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1740–1756
Prompt diagnosis of septic arthritis (SA) in acute native hot joints is essential for avoiding unnecessary antibiotics and hospital admissions. We evaluated the utility of synovial fluid (SF) and serum tests in differentiating causes of acute hot joints.
COVID-19 vaccination in systemic lupus erythematosus: a systematic review of its effectiveness, immunogenicity, flares and acceptance
Shaun Ye Song Tan, Aaron Mingyang Yee, Jackie Jia Lin Sim, Cynthia Ciwei Lim
doi : 10.1093/rheumatology/keac604
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1757–1772
COVID-19 infection is associated with significant morbidity in systemic lupus erythematosus but is potentially preventable by vaccination, although the impact of the myriad vaccines among SLE patients is not established. We aimed to assess the effectiveness, efficacy, acceptance and safety of COVID-19 vaccination in SLE.
Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin?
Mrinalini Dey, György Nagy, Elena Nikiphorou
doi : 10.1093/rheumatology/keac584
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1773–1779
Despite the improvement in treatment for people with RA, ∼30% of patients remain symptomatic in the presence of optimized medical therapy, described as having ‘difficult-to-treat’ (D2T) RA. The average patient with RA has 1.6 other clinical conditions, which accumulate over time.
The role of B cells in the pathogenesis of systemic sclerosis: an update
Lazaros I Sakkas, Christina G Katsiari, Dimitrios Daoussis, Dimitrios P Bogdanos
doi : 10.1093/rheumatology/keac578
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1780–1786
The pathogenesis of SSc is incompletely understood, but several lines of evidence suggest that B cells are involved. Effector B (Beff) cells are hyperactivated and produce autoantibodies (autoAbs), and regulatory B cells (Bregs) are decreased, although a recent study reported a defect in central B cell tolerance.
Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice
Baptiste Chevet, Divi Cornec, Marta Casal Moura, Emilie Cornec-Le Gall, Fernando C Fervenza, Kenneth J Warrington, Ulrich Specks, Alvise Berti
doi : 10.1093/rheumatology/keac623
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1787–1803
ANCA-associated vasculitides (AAV) are a group of rare, primary, systemic necrotizing small-vessel vasculitides. Granulomatosis with polyangiitis and microscopic polyangiitis account for ∼80–90% of all AAV.
Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE
Eduardo Mysler, Yoshiya Tanaka, Arthur Kavanaugh, Daniel Aletaha, Peter C Taylor, In-Ho Song, Tim Shaw, Yanna Song, Ryan DeMasi, Mira Ali, Roy Fleischmann
doi : 10.1093/rheumatology/keac477
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1804–1813
Evaluate the importance of treatment sequencing in SELECT-COMPARE, assessing potential differences between starting upadacitinib or adalimumab therapy following inadequate MTX response.
Association between beverage consumption and risk of rheumatoid arthritis: a prospective study from the French E3N Cohort
Sophia Ascione, François Barde, Fanny Artaud, Yann Nguyen, Conor Macdonald, Xavier Mariette, Marie-Christine Boutron-Ruault, Carine Salliot, Raphaèle Seror
doi : 10.1093/rheumatology/keac544
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1814–1823
To assess the relationship between consumption of largely consumed beverages (coffee, tea, alcohol and soft drinks) and the risk of RA.
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids
Linda Hartman, José A P da Silva, Frank Buttgereit, Maurizio Cutolo, Daniela Opris-Belinski, Zoltan Szekanecz, Pavol Masaryk, Marieke J H Voshaar, Martijn W Heymans, Willem F Lems, Désirée M F M van der Heijde, Maarten Boers
doi : 10.1093/rheumatology/keac547
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1824–1833
To develop prediction models for individual patient harm and benefit outcomes in elderly patients with RA and comorbidities treated with chronic low-dose glucocorticoid therapy or placebo.
Whole grain consumption and risk of radiographic knee osteoarthritis: a prospective study from the Osteoarthritis Initiative
Tong Liu, Chang Xu, Jeffery B Driban, Ge-yu Liang, Xue-hong Zhang, Frank B Hu, Timothy McAlindon, Bing Lu
doi : 10.1093/rheumatology/keac517
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1834–1840
To assess the association of whole grain consumption with the risk of incident knee OA.
Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT
Ann-Sophie De Craemer, Liselotte Deroo, Thomas Renson, Ine Desimpele, Lauren Delmez, Saskia Decuman, Xavier Janssens, Annelies Boonen, Dirk Elewaut, Philippe Carron, Filip Van den Bosch
doi : 10.1093/rheumatology/keac529
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1841–1850
This study aimed to (i) investigate actual work participation in Belgian spondyloarthritis (SpA) patients compared with the general population, and (ii) identify determinants of work-related outcomes.
Brodalumab, an anti–interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 study
Tae-Hwan Kim, Mitsumasa Kishimoto, James Cheng-Chung Wei, Haeyoun Jeong, Akiyo Nozaki, Shigeto Kobayashi
doi : 10.1093/rheumatology/keac522
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1851–1859
To evaluate the long-term efficacy and safety of brodalumab, a fully human anti–interleukin-17 receptor A monoclonal antibody, in patients with axial spondyloarthritis (axSpA).
Association of mycophenolate and azathioprine use with cognitive function in systemic lupus
Chrisanna Dobrowolski, John McGinley, Melissa Fazzari, Jiandong Su, Kathleen S Bingham, Nicole Anderson, Lesley Ruttan, Dorcas E Beaton, Joan E Wither, Maria Carmela Tartaglia, Mahta Kakvan, Dennisse Bonilla, May Y Choi, Marvin J Fritzler, Juan Pablo Diaz Martinez, Patricia Katz, Robin Green, Chaim Putterman, Zahi Touma
doi : 10.1093/rheumatology/keac540
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1860–1869
Cognitive dysfunction (CD) is a common manifestation of SLE that can have detrimental consequences for those affected. To date, no treatments have been approved for SLE-CD. This study aims to assess the association of azathioprine (AZA) and mycophenolate (MMF) use with SLE-CD, given that these medications have demonstrated neuroprotective qualities in prior studies.
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial
Christopher P Denton, Nicole S Goh, Stephen M Humphries, Toby M Maher, Robert Spiera, Anand Devaraj, Lawrence Ho, Christian Stock, Elvira Erhardt, Margarida Alves, Athol U Wells
doi : 10.1093/rheumatology/keac535
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1870–1876
To assess associations between the extent of fibrotic interstitial lung disease (ILD) and forced vital capacity (FVC) at baseline and change in FVC over 52 weeks in patients with systemic sclerosis-associated ILD (SSc-ILD) in the SENSCIS trial.
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
David Roofeh, Kevin K Brown, Ella A Kazerooni, Donald Tashkin, Shervin Assassi, Fernando Martinez, Athol U Wells, Ganesh Raghu, Christopher P Denton, Lorinda Chung, Anna-Maria Hoffmann-Vold, Oliver Distler, Kerri A Johannson, Yannick Allanore, Eric L Matteson, Leticia Kawano-Dourado, John D Pauling, James R Seibold, Elizabeth R Volkmann, Simon L F Walsh, Chester V Oddis, Eric S White, Shaney L Barratt, Elana J Bernstein, Robyn T Domsic, Paul F Dellaripa, Richard Conway, Ivan Rosas, Nitin Bhatt, Vivien Hsu, Francesca Ingegnoli, Bashar Kahaleh, Puneet Garcha, Nishant Gupta, Surabhi Khanna, Peter Korsten, Celia Lin, Stephen C Mathai, Vibeke Strand, Tracy J Doyle, Virginia Steen, Donald F Zoz, Juan Ovalles-Bonilla, Ignasi Rodriguez-Pinto, Padmanabha D Shenoy, Andrew Lewandoski, Elizabeth Belloli, Alain Lescoat, Vivek Nagaraja, Wen Ye, Suiyuan Huang, Toby Maher, Dinesh Khanna
doi : 10.1093/rheumatology/keac557
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1877–1886
To establish a framework by which experts define disease subsets in systemic sclerosis associated interstitial lung disease (SSc-ILD).
Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis
Anne Christine Bull Haaversen, Lene Kristin Brekke, Tanaz A Kermani, Øyvind Molberg, Andreas P Diamantopoulos
doi : 10.1093/rheumatology/keac478
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1887–1894
To compare limited with a more extended ultrasound examination (anteromedial ultrasound, A2-ultrasound) to detect large vessel (LV) involvement in patients with newly diagnosed GCA.
Comparative risk of blindness and vision-threatening ocular comorbidities in patients with Behçet’s disease versus the general population
Se Rim Choi, Joo Young Shin, Anna Shin, Hokyung Choung, Se Joon Woo, Sang Jun Park, You-Jung Ha, Yun Jong Lee, Eun Bong Lee, Jin Kyun Park, Eun Ha Kang
doi : 10.1093/rheumatology/keac531
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1895–1902
To compare the risk of blindness and vision-threatening ocular comorbidities in patients with Behçet’s disease (BD) vs the general population.
Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Behçet disease
Rabia Deniz, Zeliha Emrence, Yasemin Yalçınkaya, Bahar Artım Esen, Murat İnanç, Mahdume Lale Öcal, Ahmet Gül
doi : 10.1093/rheumatology/keac543
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1903–1909
The skin pathergy test (SPT) is an important tool in the diagnosis of Behçet disease (BD), but its decreasing sensitivity over years has resulted in less frequent use in the clinical practice. This study aimed to improve the sensitivity of the SPT without compromising its specificity.
Longitudinal study of patients with antimelanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease
Xinyue Lian, Yan Ye, Jing Zou, Chunmei Wu, Shuang Ye, Qiang Guo, Sheng Chen, Liangjing Lu, Ran Wang, Qiong Fu, Chunde Bao
doi : 10.1093/rheumatology/keac525
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1910–1919
To describe the 8-year longitudinal study and long-term prognosis of a large inception cohort of anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive (MDA5+) DM-interstitial lung disease (ILD) patients.
Patients’ and parents’ satisfaction to improve patient care in JIA: factors determining acceptable symptom state measured with JAMAR
Emanuela Del Giudice, Sytze de Roock, Sebastiaan J Vastert, Nico M Wulffraat, Joost F Swart, Evert H P van Dijkhuizen
doi : 10.1093/rheumatology/keac658
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1920–1925
The aim of this study was to identify factors associated with patients’ and parents’ reported satisfaction with JIA care, measured with the juvenile arthritis child and parent acceptable symptom state (JA-CASS and JA-PASS, respectively).
Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis
Lianne Kearsley-Fleet, Eileen Baildam, Michael W Beresford, Sharon Douglas, Helen E Foster, Taunton R Southwood, Kimme L Hyrich, Coziana Ciurtin
doi : 10.1093/rheumatology/keac463
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1926–1935
Clinicians concerned about long-term safety of biologics in JIA may consider tapering or stopping treatment once remission is achieved despite uncertainty in maintaining drug-free remission. This analysis aims to (i) calculate how many patients with JIA stop biologics for remission, (ii) calculate how many later re-start therapy and after how long, and (iii) identify factors associated with re-starting biologics.
Continuing specialist care into adulthood in young people with juvenile idiopathic arthritis: a retrospective cohort study using electronic health records in England
Ruth E Costello, Lianne Kearsley-Fleet, Janet E McDonagh, Kimme L Hyrich, Jenny H Humphreys
doi : 10.1093/rheumatology/keac497
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1936–1943
This study aimed to measure (1) the proportion of children who continue to receive specialist care (rheumatology/ophthalmology) as adults, (2) the characteristics associated with continuing specialist care, and (3) the frequency of specialist care appointments in both paediatric and adult services.
Clinically suspect arthralgia patients with a low educational attainment have an increased risk of developing inflammatory arthritis
Sarah J H Khidir, Anna M P Boeren, Annelies Boonen, Pascal H P de Jong, Elise van Mulligen, Annette H M van der Helm-van Mil
doi : 10.1093/rheumatology/keac446
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1944–1949
Cross-sectional studies have shown that rheumatoid arthritis is more prevalent among people with a lower educational attainment. No longitudinal data are present on educational attainment in the at-risk phase of clinically suspect arthralgia (CSA).
Baseline knee extension may be associated with volumetric cartilage loss in the anterolateral tibia: data from the Osteoarthritis Initiative
T Mark Campbell, Katherine Reilly, Odette Laneuville, Hans K Uhthoff, Guy Trudel
doi : 10.1093/rheumatology/keac562
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1950–1954
Animal studies suggest regional unloading of the knee due to flexion contracture (FC) results in cartilage loss in the anterior tibia. We looked for an association between the range of knee extension and articular cartilage thickness in the tibia of patients with knee OA, using quantitative MRI data from the OA Initiative.
A novel long non-coding RNA, lnc-RNU12, influences the T-cell cycle via c-JUN and CCNL2 in rheumatoid arthritis
Xing-Bo Mo, Yang-Hua Sun, Long-Fei Wu, Pei He, Rong-Rong Cao, Xin Lu, Yong-Hong Zhang, Fei-Yan Deng, Shu-Feng Lei
doi : 10.1093/rheumatology/keac553
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1955–1963
Long non-coding RNAs (lncRNAs) play important roles in RA pathogenesis. However, specific lncRNAs that regulate gene expression in RA pathogenesis are poorly known. This study was undertaken to characterize a novel lncRNA (lnc-RNU12) that has a lower-than-normal expression level in RA patients.
Individual participant data meta-analysis of metabolomics on sustained knee pain in primary osteoarthritis patients
Christie A Costello, Jason S Rockel, Ming Liu, Rajiv Gandhi, Anthony V Perruccio, Y Raja Rampersaud, Nizar N Mahomed, Proton Rahman, Edward W Randell, Andrew Furey, Mohit Kapoor, Guangju Zhai
doi : 10.1093/rheumatology/keac545
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1964–1971
Knee pain is the major driver for OA patients to seek healthcare, but after pursuing both conservative and surgical pain interventions, ∼20% of patients continue to report long-term pain following total knee arthroplasty (TKA). This study aimed to identify a metabolomic signature for sustained knee pain after TKA to elucidate possible underlying mechanisms.
Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset gout
Can Wang, Jie Lu, Wenyan Sun, Tony R Merriman, Nicola Dalbeth, Zhongjun Wang, Xuefeng Wang, Lin Han, Lingling Cui, Xinde Li, Aichang Ji, Hailong Li, Xiaopeng Ji, Yuwei He, Changgui Li, Zhen Liu
doi : 10.1093/rheumatology/keac507
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1972–1979
Oxylipins modulate inflammation via complex pathways. The oxylipin profile in gout remains unexplored. In this study, we systemically profiled oxylipins in young men and identified new oxylipin biomarkers for clinical use in differentiating gout from hyperuricaemia.
An ankylosing spondylitis risk variant alters osteoclast differentiation
Fangyi Wu, Xuling Han, Jing Liu, Zhenghua Zhang, Kexiang Yan, Beilan Wang, Lin Yang, Hejian Zou, Chengde Yang, Wei Huang, Li Jin, Jiucun Wang, Feng Qian, Zhenmin Niu
doi : 10.1093/rheumatology/keac542
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1980–1987
To explore whether the variants in non MHC proteasome gene are associated with AS and explain the role of the variant in the disease.
SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis
Eri Itotagawa, Yoshihiko Tomofuji, Yasuhiro Kato, Hachiro Konaka, Kohei Tsujimoto, JeongHoon Park, Daiki Nagira, Takehiro Hirayama, Tatsunori Jo, Toru Hirano, Takayoshi Morita, Masayuki Nishide, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Yukinori Okada, Hyota Takamatsu, Atsushi Kumanogoh
doi : 10.1093/rheumatology/keac528
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1988–1997
B-cell activating factor (BAFF) is implicated in SLE pathogenesis. Blocking BAFF signalling has contributed to reducing glucocorticoid dosage and preventing organ damage. However, clinical characteristics of patients who may benefit from this therapy are not yet fully elucidated. Therefore, we identified patients with high BAFF-bioactivity to investigate their clinical characteristics and BAFF-producing cells.
Down-regulated FcγRII expression on plasma cells is associated with the disease activity of ANCA-associated vasculitis
Chen Wang, Yan Gong, Ran You, Zhi-Ying Li, Ming-Hui Zhao, Min Chen
doi : 10.1093/rheumatology/keac524
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1998–2004
Inhibitory FcγRIIB/CD32B on B cells are critical for immunity regulation to help maintain peripheral tolerance. Altered FcγRIIB expression on B cells has been observed in several autoimmune diseases, and animal studies have suggested that FcγRIIB on B cells participates in the pathogenesis of ANCA-associated vasculitis (AAV). Here, we investigated the expression of FcγRII (FcγRIIB) on various B cell subsets and the correlation of FcγRII/CD32 expression with disease activity in AAV patients.
Eosinophilic fasciitis (Shulman syndrome)—recognition of the histological spectrum allows for new insights into possible pathomechanisms
Debora Pehl, Corinna Preuße, Yves Allenbach, Olivier Benveniste, Philipp Dittert, Rieke Alten, Andreas Krause, Norman Görl, Michael Zänker, Hans-Hilmar Goebel, Udo Schneider, Werner Stenzel
doi : 10.1093/rheumatology/keac526
Rheumatology, Volume 62, Issue 5, May 2023, Pages 2005–2014
EF is a rare disease characterized by fibrosis and inflammation of the fascia, scleroderma-like skin indurations and optional blood eosinophilia. We aimed to expand the knowledge about its aetiology and pathogenesis.
Genetic architecture underlying IgG-RF production is distinct from that of IgM-RF
Ai Yaku, Yuki Ishikawa, Takeshi Iwasaki, Ryosuke Hiwa, Keitaro Matsuo, Hiroh Saji, Kimiko Yurugi, Yasuo Miura, Moritoshi Furu, Hiromu Ito, Takao Fujii, Taira Maekawa, Motomu Hashimoto, Koichiro Ohmura, Tsuneyo Mimori, Chikashi Terao
doi : 10.1093/rheumatology/keac593
Rheumatology, Volume 62, Issue 5, May 2023, Pages 2015–2020
HLA-DRB1 alleles, particularly the shared epitope (SE) alleles, are strongly associated with RA. Different genetic structures underlie the production of the various autoantibodies in RA. While extensive genetic analyses have been conducted to generate a detailed profile of ACPA, a representative autoantibody in RA, the genetic architecture underlying subfractions of RF other than IgM-RF, namely IgG-RF, known to be associated with rheumatoid vasculitis, is not well understood.
Correction to: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
doi : 10.1093/rheumatology/keac686
Rheumatology, Volume 62, Issue 5, May 2023, Page 2021
Correction to: Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA)
doi : 10.1093/rheumatology/kead004
Rheumatology, Volume 62, Issue 5, May 2023, Page 2022
The clinical impact of systemic sclerosis-related calcinosis—results of a patient survey
Emma Pearson, Emma Blamont, Sarah Wilkinson, Ariane L Herrick
doi : 10.1093/rheumatology/keac538
Rheumatology, Volume 62, Issue 5, May 2023, Pages e140–e141
Specialist nurse training in ultrasonography for the diagnosis of giant cell arteritis
Georgina Ducker, Chetan B Mukhtyar
doi : 10.1093/rheumatology/keac591
Rheumatology, Volume 62, Issue 5, May 2023, Pages e142–e143
SNP-based heritability estimates of gout and its subtypes determined by genome-wide association studies of clinically defined gout
Yu Toyoda, Masahiro Nakatochi, Akiyoshi Nakayama, Yusuke Kawamura, Hirofumi Nakaoka, Kenji Wakai, Keitaro Matsuo, Hirotaka Matsuo, for the Japan Gout Genomics Consortium
doi : 10.1093/rheumatology/keac597
Rheumatology, Volume 62, Issue 5, May 2023, Pages e144–e146
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study
Mrinalini Dey, Naveen R, Elena Nikiphorou, Parikshit Sen, Sreoshy Saha, James B Lilleker, Vishwesh Agarwal, Sinan Kardes, Jessica Day, Marcin Milchert, Mrudula Joshi, Tamer Gheita, Babur Salim, Tsvetelina Velikova, Abraham Edgar Gracia-Ramos, Ioannis Parodis, Albert Selva O’Callaghan, Minchul Kim, Tulika Chatterjee, Ai Lyn Tan, Ashima Makol, Arvind Nune, Lorenzo Cavagna, Miguel A Saavedra, Samuel Katsuyuki Shinjo, Nelly Ziade, Johannes Knitza, Masataka Kuwana, Oliver Distler, Bhupen Barman, Yogesh Preet Singh, Rajiv Ranjan, Avinash Jain, Sapan C Pandya, Rakesh Kumar Pilania, Aman Sharma, Manesh M Manoj, Vikas Gupta, Chengappa G Kavadichanda, Pradeepta Sekhar Patro, Sajal Ajmani, Sanat Phatak, Rudra Prosad Goswami, Abhra Chandra Chowdhury, Ashish Jacob Mathew, Padnamabha Shenoy, Ajay Asranna, Keerthi Talari Bommakanti, Anuj Shukla, Arunkumar R Pande, Kunal Chandwar, John D Pauling, Chris Wincup, Döndü Ãœsküdar Cansu, Erick Adrian Zamora Tehozol, Jorge Rojas Serrano, Ignacio GarcÃa-De La Torre, Nicoletta Del Papa, Gianluca Sambataro, Atzeni Fabiola, Marcello Govoni, Simone Parisi, Elena Bartoloni Bocci, Gian Domenico Sebastiani, Enrico Fusaro, Marco Sebastiani, Luca Quartuccio, Franco Franceschini, Pier Paolo Sainaghi, Giovanni Orsolini, Rossella De Angelis, Maria Giovanna Danielli, Vincenzo Venerito, Lisa S Traboco, Leonardo Santos Hoff, Suryo Anggoro Kusumo Wibowo, Stylianos Tomaras, Daman Langguth, Vidya Limaye, Merrilee Needham, Nilesh Srivastav, Akira Yoshida, Ran Nakashima, Shinji Sato, Naoki Kimura, Yuko Kaneko, Jesús Loarce-Martos, Sergio Prieto-González, Albert Gil-Vila, Raquel Arà nega Gonzalez, Hector Chinoy, Vikas Agarwal, Rohit Aggarwal, Latika Gupta, COVAD Study Group
doi : 10.1093/rheumatology/keac603
Rheumatology, Volume 62, Issue 5, May 2023, Pages e147–e152
Smartphone images of digital ulcers provide a clear picture of disease progression for the first rheumatology visit
Anastasia-Vasiliki Madenidou, Graham Dinsdale, Muditha Samaranayaka, Lindsay Muir, William G Dixon, Ariane L Herrick
doi : 10.1093/rheumatology/keac561
Rheumatology, Volume 62, Issue 5, May 2023, Pages e153–e154
A new autoantibody to valyl transfer RNA synthetase associated with anti-synthetase syndrome
Tsuneo Sasai, Ran Nakashima, Mirei Shirakashi, Ryosuke Hiwa, Hideaki Tsuji, Koji Kitagori, Shuji Akizuki, Hajime Yoshifuji, Tsuneyo Mimori, Akio Morinobu
doi : 10.1093/rheumatology/keac569
Rheumatology, Volume 62, Issue 5, May 2023, Pages e155–e157
Monkeypox in a patient with undifferentiated connective tissue disease
Tommaso Clemente, Diana Canetti, Lorenzo Dagna, Caterina Uberti Foppa, Antonella Castagna, Vincenzo Spagnuolo, Silvia Nozza, Corrado Campochiaro
doi : 10.1093/rheumatology/keac568
Rheumatology, Volume 62, Issue 5, May 2023, Pages e158–e160
Guillain–Barré syndrome is associated with ixekizumab in a patient with pustular psoriasis
Haijun Liu, Qianhua Li, Qingfeng Li, Xia Li, Lie Dai
doi : 10.1093/rheumatology/keac609
Rheumatology, Volume 62, Issue 5, May 2023, Pages e161–e163,
Comment on: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding
Karen Schreiber, Margreta Frishman, Beverley J Hunt
doi : 10.1093/rheumatology/keac700
Rheumatology, Volume 62, Issue 5, May 2023, Pages e164–e165
Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3
Lieselotte Vande Walle, Mohamed Lamkanfi
doi : 10.1093/rheumatology/keac717
Rheumatology, Volume 62, Issue 5, May 2023, Pages e166–e167
Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply
Alexander N R Weber, Ana Tapia-Abellán, Xiao Liu, Juan I Aróstegui, Pablo PelegrÃn, Tatjana Welzel, Jasmin B Kuemmerle-Deschner
doi : 10.1093/rheumatology/keac718
Rheumatology, Volume 62, Issue 5, May 2023, Pages e168–e169
An unusual presentation of cutaneous lupus erythematosus as a unilateral periorbital erythematous-to-violaceous oedematous plaque
Yexiao Wang, Chaocheng Liu, Hui Zhou
doi : 10.1093/rheumatology/keac514
Rheumatology, Volume 62, Issue 5, May 2023, Pages e170–e171
Text neck misdiagnosed as fibromyalgia
Taro Horino, Hiroshi Ohnishi, Masahiro Komori, Yoshio Terada
doi : 10.1093/rheumatology/keac571
Rheumatology, Volume 62, Issue 5, May 2023, Pages e172–e173
Scalp necrosis during a giant cell arteritis relapse triggered by a VZV infection
Thibaud Chazal, Gaelle Clavel
doi : 10.1093/rheumatology/keac570
Rheumatology, Volume 62, Issue 5, May 2023, Page e174
COP27 Climate Change Conference: urgent action needed for Africa and the world: Wealthy nations must step up support for Africa and vulnerable countries in addressing past, present and future impacts of climate change
Lukoye Atwoli, Gregory E Erhabor, Aiah A Gbakima, Abraham Haileamlak, Jean-Marie Kayembe Ntumba, James Kigera, Laurie Laybourn-Langton, Bob Mash, Joy Muhia, Fhumulani Mavis Mulaudzi, David Ofori-Adjei, Friday Okonofua, Arash Rashidian, Maha El-Adawy, Siaka Sidibé, Abdelmadjid Snouber, James Tumwine, Mohammad Sahar Yassien, Paul Yonga, Lilia Zakhama, Chris Zielinski
doi : 10.1093/rheumatology/keac573
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1721–1723
The use of combination monoclonal antibody therapies in lupus—where are we now?
Joana Rua, Maria Dall’Era, David Isenberg
doi : 10.1093/rheumatology/keac482
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1724–1729
More to B: the growing evidence to inform targeting B cells in scleroderma
Silvia Laura Bosello, Edward M Vital, Francesco Del Galdo
doi : 10.1093/rheumatology/keac677
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1730–1732
How extensively should ultrasound be performed in suspected giant cell arteritis?
Wolfgang A Schmidt
doi : 10.1093/rheumatology/keac616
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1733–1735
The influence of low educational attainment on progress in rheumatoid arthritis: nature or nurture?
Marwan Bukhari
doi : 10.1093/rheumatology/keac615
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1736–1737
Which should be first: biologic DMARDs or Janus kinase inhibitors?
Tatsuya Koike
doi : 10.1093/rheumatology/keac629
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1738–1739
Assessment and diagnosis of the acute hot joint: a systematic review and meta-analysis
Mrinalini Dey, Mariam Al-Attar, Leticia Peruffo, Ashley Coope, Sizheng Steven Zhao, Stephen Duffield, Nicola Goodson
doi : 10.1093/rheumatology/keac606
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1740–1756
Prompt diagnosis of septic arthritis (SA) in acute native hot joints is essential for avoiding unnecessary antibiotics and hospital admissions. We evaluated the utility of synovial fluid (SF) and serum tests in differentiating causes of acute hot joints.
COVID-19 vaccination in systemic lupus erythematosus: a systematic review of its effectiveness, immunogenicity, flares and acceptance
Shaun Ye Song Tan, Aaron Mingyang Yee, Jackie Jia Lin Sim, Cynthia Ciwei Lim
doi : 10.1093/rheumatology/keac604
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1757–1772
COVID-19 infection is associated with significant morbidity in systemic lupus erythematosus but is potentially preventable by vaccination, although the impact of the myriad vaccines among SLE patients is not established. We aimed to assess the effectiveness, efficacy, acceptance and safety of COVID-19 vaccination in SLE.
Comorbidities and extra-articular manifestations in difficult-to-treat rheumatoid arthritis: different sides of the same coin?
Mrinalini Dey, György Nagy, Elena Nikiphorou
doi : 10.1093/rheumatology/keac584
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1773–1779
Despite the improvement in treatment for people with RA, ∼30% of patients remain symptomatic in the presence of optimized medical therapy, described as having ‘difficult-to-treat’ (D2T) RA. The average patient with RA has 1.6 other clinical conditions, which accumulate over time.
The role of B cells in the pathogenesis of systemic sclerosis: an update
Lazaros I Sakkas, Christina G Katsiari, Dimitrios Daoussis, Dimitrios P Bogdanos
doi : 10.1093/rheumatology/keac578
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1780–1786
The pathogenesis of SSc is incompletely understood, but several lines of evidence suggest that B cells are involved. Effector B (Beff) cells are hyperactivated and produce autoantibodies (autoAbs), and regulatory B cells (Bregs) are decreased, although a recent study reported a defect in central B cell tolerance.
Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice
Baptiste Chevet, Divi Cornec, Marta Casal Moura, Emilie Cornec-Le Gall, Fernando C Fervenza, Kenneth J Warrington, Ulrich Specks, Alvise Berti
doi : 10.1093/rheumatology/keac623
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1787–1803
ANCA-associated vasculitides (AAV) are a group of rare, primary, systemic necrotizing small-vessel vasculitides. Granulomatosis with polyangiitis and microscopic polyangiitis account for ∼80–90% of all AAV.
Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE
Eduardo Mysler, Yoshiya Tanaka, Arthur Kavanaugh, Daniel Aletaha, Peter C Taylor, In-Ho Song, Tim Shaw, Yanna Song, Ryan DeMasi, Mira Ali, Roy Fleischmann
doi : 10.1093/rheumatology/keac477
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1804–1813
Evaluate the importance of treatment sequencing in SELECT-COMPARE, assessing potential differences between starting upadacitinib or adalimumab therapy following inadequate MTX response.
Association between beverage consumption and risk of rheumatoid arthritis: a prospective study from the French E3N Cohort
Sophia Ascione, François Barde, Fanny Artaud, Yann Nguyen, Conor Macdonald, Xavier Mariette, Marie-Christine Boutron-Ruault, Carine Salliot, Raphaèle Seror
doi : 10.1093/rheumatology/keac544
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1814–1823
To assess the relationship between consumption of largely consumed beverages (coffee, tea, alcohol and soft drinks) and the risk of RA.
Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids
Linda Hartman, José A P da Silva, Frank Buttgereit, Maurizio Cutolo, Daniela Opris-Belinski, Zoltan Szekanecz, Pavol Masaryk, Marieke J H Voshaar, Martijn W Heymans, Willem F Lems, Désirée M F M van der Heijde, Maarten Boers
doi : 10.1093/rheumatology/keac547
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1824–1833
To develop prediction models for individual patient harm and benefit outcomes in elderly patients with RA and comorbidities treated with chronic low-dose glucocorticoid therapy or placebo.
Whole grain consumption and risk of radiographic knee osteoarthritis: a prospective study from the Osteoarthritis Initiative
Tong Liu, Chang Xu, Jeffery B Driban, Ge-yu Liang, Xue-hong Zhang, Frank B Hu, Timothy McAlindon, Bing Lu
doi : 10.1093/rheumatology/keac517
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1834–1840
To assess the association of whole grain consumption with the risk of incident knee OA.
Work participation is unaffected in Belgian spondyloarthritis patients: data from the BelGian Inflammatory Arthritis and SpoNdylitis cohorT
Ann-Sophie De Craemer, Liselotte Deroo, Thomas Renson, Ine Desimpele, Lauren Delmez, Saskia Decuman, Xavier Janssens, Annelies Boonen, Dirk Elewaut, Philippe Carron, Filip Van den Bosch
doi : 10.1093/rheumatology/keac529
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1841–1850
This study aimed to (i) investigate actual work participation in Belgian spondyloarthritis (SpA) patients compared with the general population, and (ii) identify determinants of work-related outcomes.
Brodalumab, an anti–interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 study
Tae-Hwan Kim, Mitsumasa Kishimoto, James Cheng-Chung Wei, Haeyoun Jeong, Akiyo Nozaki, Shigeto Kobayashi
doi : 10.1093/rheumatology/keac522
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1851–1859
To evaluate the long-term efficacy and safety of brodalumab, a fully human anti–interleukin-17 receptor A monoclonal antibody, in patients with axial spondyloarthritis (axSpA).
Association of mycophenolate and azathioprine use with cognitive function in systemic lupus
Chrisanna Dobrowolski, John McGinley, Melissa Fazzari, Jiandong Su, Kathleen S Bingham, Nicole Anderson, Lesley Ruttan, Dorcas E Beaton, Joan E Wither, Maria Carmela Tartaglia, Mahta Kakvan, Dennisse Bonilla, May Y Choi, Marvin J Fritzler, Juan Pablo Diaz Martinez, Patricia Katz, Robin Green, Chaim Putterman, Zahi Touma
doi : 10.1093/rheumatology/keac540
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1860–1869
Cognitive dysfunction (CD) is a common manifestation of SLE that can have detrimental consequences for those affected. To date, no treatments have been approved for SLE-CD. This study aims to assess the association of azathioprine (AZA) and mycophenolate (MMF) use with SLE-CD, given that these medications have demonstrated neuroprotective qualities in prior studies.
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial
Christopher P Denton, Nicole S Goh, Stephen M Humphries, Toby M Maher, Robert Spiera, Anand Devaraj, Lawrence Ho, Christian Stock, Elvira Erhardt, Margarida Alves, Athol U Wells
doi : 10.1093/rheumatology/keac535
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1870–1876
To assess associations between the extent of fibrotic interstitial lung disease (ILD) and forced vital capacity (FVC) at baseline and change in FVC over 52 weeks in patients with systemic sclerosis-associated ILD (SSc-ILD) in the SENSCIS trial.
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease
David Roofeh, Kevin K Brown, Ella A Kazerooni, Donald Tashkin, Shervin Assassi, Fernando Martinez, Athol U Wells, Ganesh Raghu, Christopher P Denton, Lorinda Chung, Anna-Maria Hoffmann-Vold, Oliver Distler, Kerri A Johannson, Yannick Allanore, Eric L Matteson, Leticia Kawano-Dourado, John D Pauling, James R Seibold, Elizabeth R Volkmann, Simon L F Walsh, Chester V Oddis, Eric S White, Shaney L Barratt, Elana J Bernstein, Robyn T Domsic, Paul F Dellaripa, Richard Conway, Ivan Rosas, Nitin Bhatt, Vivien Hsu, Francesca Ingegnoli, Bashar Kahaleh, Puneet Garcha, Nishant Gupta, Surabhi Khanna, Peter Korsten, Celia Lin, Stephen C Mathai, Vibeke Strand, Tracy J Doyle, Virginia Steen, Donald F Zoz, Juan Ovalles-Bonilla, Ignasi Rodriguez-Pinto, Padmanabha D Shenoy, Andrew Lewandoski, Elizabeth Belloli, Alain Lescoat, Vivek Nagaraja, Wen Ye, Suiyuan Huang, Toby Maher, Dinesh Khanna
doi : 10.1093/rheumatology/keac557
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1877–1886
To establish a framework by which experts define disease subsets in systemic sclerosis associated interstitial lung disease (SSc-ILD).
Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis
Anne Christine Bull Haaversen, Lene Kristin Brekke, Tanaz A Kermani, Øyvind Molberg, Andreas P Diamantopoulos
doi : 10.1093/rheumatology/keac478
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1887–1894
To compare limited with a more extended ultrasound examination (anteromedial ultrasound, A2-ultrasound) to detect large vessel (LV) involvement in patients with newly diagnosed GCA.
Comparative risk of blindness and vision-threatening ocular comorbidities in patients with Behçet’s disease versus the general population
Se Rim Choi, Joo Young Shin, Anna Shin, Hokyung Choung, Se Joon Woo, Sang Jun Park, You-Jung Ha, Yun Jong Lee, Eun Bong Lee, Jin Kyun Park, Eun Ha Kang
doi : 10.1093/rheumatology/keac531
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1895–1902
To compare the risk of blindness and vision-threatening ocular comorbidities in patients with Behçet’s disease (BD) vs the general population.
Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Behçet disease
Rabia Deniz, Zeliha Emrence, Yasemin Yalçınkaya, Bahar Artım Esen, Murat İnanç, Mahdume Lale Öcal, Ahmet Gül
doi : 10.1093/rheumatology/keac543
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1903–1909
The skin pathergy test (SPT) is an important tool in the diagnosis of Behçet disease (BD), but its decreasing sensitivity over years has resulted in less frequent use in the clinical practice. This study aimed to improve the sensitivity of the SPT without compromising its specificity.
Longitudinal study of patients with antimelanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease
Xinyue Lian, Yan Ye, Jing Zou, Chunmei Wu, Shuang Ye, Qiang Guo, Sheng Chen, Liangjing Lu, Ran Wang, Qiong Fu, Chunde Bao
doi : 10.1093/rheumatology/keac525
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1910–1919
To describe the 8-year longitudinal study and long-term prognosis of a large inception cohort of anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive (MDA5+) DM-interstitial lung disease (ILD) patients.
Patients’ and parents’ satisfaction to improve patient care in JIA: factors determining acceptable symptom state measured with JAMAR
Emanuela Del Giudice, Sytze de Roock, Sebastiaan J Vastert, Nico M Wulffraat, Joost F Swart, Evert H P van Dijkhuizen
doi : 10.1093/rheumatology/keac658
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1920–1925
The aim of this study was to identify factors associated with patients’ and parents’ reported satisfaction with JIA care, measured with the juvenile arthritis child and parent acceptable symptom state (JA-CASS and JA-PASS, respectively).
Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis
Lianne Kearsley-Fleet, Eileen Baildam, Michael W Beresford, Sharon Douglas, Helen E Foster, Taunton R Southwood, Kimme L Hyrich, Coziana Ciurtin
doi : 10.1093/rheumatology/keac463
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1926–1935
Clinicians concerned about long-term safety of biologics in JIA may consider tapering or stopping treatment once remission is achieved despite uncertainty in maintaining drug-free remission. This analysis aims to (i) calculate how many patients with JIA stop biologics for remission, (ii) calculate how many later re-start therapy and after how long, and (iii) identify factors associated with re-starting biologics.
Continuing specialist care into adulthood in young people with juvenile idiopathic arthritis: a retrospective cohort study using electronic health records in England
Ruth E Costello, Lianne Kearsley-Fleet, Janet E McDonagh, Kimme L Hyrich, Jenny H Humphreys
doi : 10.1093/rheumatology/keac497
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1936–1943
This study aimed to measure (1) the proportion of children who continue to receive specialist care (rheumatology/ophthalmology) as adults, (2) the characteristics associated with continuing specialist care, and (3) the frequency of specialist care appointments in both paediatric and adult services.
Clinically suspect arthralgia patients with a low educational attainment have an increased risk of developing inflammatory arthritis
Sarah J H Khidir, Anna M P Boeren, Annelies Boonen, Pascal H P de Jong, Elise van Mulligen, Annette H M van der Helm-van Mil
doi : 10.1093/rheumatology/keac446
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1944–1949
Cross-sectional studies have shown that rheumatoid arthritis is more prevalent among people with a lower educational attainment. No longitudinal data are present on educational attainment in the at-risk phase of clinically suspect arthralgia (CSA).
Baseline knee extension may be associated with volumetric cartilage loss in the anterolateral tibia: data from the Osteoarthritis Initiative
T Mark Campbell, Katherine Reilly, Odette Laneuville, Hans K Uhthoff, Guy Trudel
doi : 10.1093/rheumatology/keac562
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1950–1954
Animal studies suggest regional unloading of the knee due to flexion contracture (FC) results in cartilage loss in the anterior tibia. We looked for an association between the range of knee extension and articular cartilage thickness in the tibia of patients with knee OA, using quantitative MRI data from the OA Initiative.
A novel long non-coding RNA, lnc-RNU12, influences the T-cell cycle via c-JUN and CCNL2 in rheumatoid arthritis
Xing-Bo Mo, Yang-Hua Sun, Long-Fei Wu, Pei He, Rong-Rong Cao, Xin Lu, Yong-Hong Zhang, Fei-Yan Deng, Shu-Feng Lei
doi : 10.1093/rheumatology/keac553
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1955–1963
Long non-coding RNAs (lncRNAs) play important roles in RA pathogenesis. However, specific lncRNAs that regulate gene expression in RA pathogenesis are poorly known. This study was undertaken to characterize a novel lncRNA (lnc-RNU12) that has a lower-than-normal expression level in RA patients.
Individual participant data meta-analysis of metabolomics on sustained knee pain in primary osteoarthritis patients
Christie A Costello, Jason S Rockel, Ming Liu, Rajiv Gandhi, Anthony V Perruccio, Y Raja Rampersaud, Nizar N Mahomed, Proton Rahman, Edward W Randell, Andrew Furey, Mohit Kapoor, Guangju Zhai
doi : 10.1093/rheumatology/keac545
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1964–1971
Knee pain is the major driver for OA patients to seek healthcare, but after pursuing both conservative and surgical pain interventions, ∼20% of patients continue to report long-term pain following total knee arthroplasty (TKA). This study aimed to identify a metabolomic signature for sustained knee pain after TKA to elucidate possible underlying mechanisms.
Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset gout
Can Wang, Jie Lu, Wenyan Sun, Tony R Merriman, Nicola Dalbeth, Zhongjun Wang, Xuefeng Wang, Lin Han, Lingling Cui, Xinde Li, Aichang Ji, Hailong Li, Xiaopeng Ji, Yuwei He, Changgui Li, Zhen Liu
doi : 10.1093/rheumatology/keac507
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1972–1979
Oxylipins modulate inflammation via complex pathways. The oxylipin profile in gout remains unexplored. In this study, we systemically profiled oxylipins in young men and identified new oxylipin biomarkers for clinical use in differentiating gout from hyperuricaemia.
An ankylosing spondylitis risk variant alters osteoclast differentiation
Fangyi Wu, Xuling Han, Jing Liu, Zhenghua Zhang, Kexiang Yan, Beilan Wang, Lin Yang, Hejian Zou, Chengde Yang, Wei Huang, Li Jin, Jiucun Wang, Feng Qian, Zhenmin Niu
doi : 10.1093/rheumatology/keac542
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1980–1987
To explore whether the variants in non MHC proteasome gene are associated with AS and explain the role of the variant in the disease.
SLE stratification based on BAFF and IFN-I bioactivity for biologics and implications of BAFF produced by glomeruli in lupus nephritis
Eri Itotagawa, Yoshihiko Tomofuji, Yasuhiro Kato, Hachiro Konaka, Kohei Tsujimoto, JeongHoon Park, Daiki Nagira, Takehiro Hirayama, Tatsunori Jo, Toru Hirano, Takayoshi Morita, Masayuki Nishide, Sumiyuki Nishida, Yoshihito Shima, Masashi Narazaki, Yukinori Okada, Hyota Takamatsu, Atsushi Kumanogoh
doi : 10.1093/rheumatology/keac528
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1988–1997
B-cell activating factor (BAFF) is implicated in SLE pathogenesis. Blocking BAFF signalling has contributed to reducing glucocorticoid dosage and preventing organ damage. However, clinical characteristics of patients who may benefit from this therapy are not yet fully elucidated. Therefore, we identified patients with high BAFF-bioactivity to investigate their clinical characteristics and BAFF-producing cells.
Down-regulated FcγRII expression on plasma cells is associated with the disease activity of ANCA-associated vasculitis
Chen Wang, Yan Gong, Ran You, Zhi-Ying Li, Ming-Hui Zhao, Min Chen
doi : 10.1093/rheumatology/keac524
Rheumatology, Volume 62, Issue 5, May 2023, Pages 1998–2004
Inhibitory FcγRIIB/CD32B on B cells are critical for immunity regulation to help maintain peripheral tolerance. Altered FcγRIIB expression on B cells has been observed in several autoimmune diseases, and animal studies have suggested that FcγRIIB on B cells participates in the pathogenesis of ANCA-associated vasculitis (AAV). Here, we investigated the expression of FcγRII (FcγRIIB) on various B cell subsets and the correlation of FcγRII/CD32 expression with disease activity in AAV patients.
Eosinophilic fasciitis (Shulman syndrome)—recognition of the histological spectrum allows for new insights into possible pathomechanisms
Debora Pehl, Corinna Preuße, Yves Allenbach, Olivier Benveniste, Philipp Dittert, Rieke Alten, Andreas Krause, Norman Görl, Michael Zänker, Hans-Hilmar Goebel, Udo Schneider, Werner Stenzel
doi : 10.1093/rheumatology/keac526
Rheumatology, Volume 62, Issue 5, May 2023, Pages 2005–2014
EF is a rare disease characterized by fibrosis and inflammation of the fascia, scleroderma-like skin indurations and optional blood eosinophilia. We aimed to expand the knowledge about its aetiology and pathogenesis.
Genetic architecture underlying IgG-RF production is distinct from that of IgM-RF
Ai Yaku, Yuki Ishikawa, Takeshi Iwasaki, Ryosuke Hiwa, Keitaro Matsuo, Hiroh Saji, Kimiko Yurugi, Yasuo Miura, Moritoshi Furu, Hiromu Ito, Takao Fujii, Taira Maekawa, Motomu Hashimoto, Koichiro Ohmura, Tsuneyo Mimori, Chikashi Terao
doi : 10.1093/rheumatology/keac593
Rheumatology, Volume 62, Issue 5, May 2023, Pages 2015–2020
HLA-DRB1 alleles, particularly the shared epitope (SE) alleles, are strongly associated with RA. Different genetic structures underlie the production of the various autoantibodies in RA. While extensive genetic analyses have been conducted to generate a detailed profile of ACPA, a representative autoantibody in RA, the genetic architecture underlying subfractions of RF other than IgM-RF, namely IgG-RF, known to be associated with rheumatoid vasculitis, is not well understood.
Correction to: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
doi : 10.1093/rheumatology/keac686
Rheumatology, Volume 62, Issue 5, May 2023, Page 2021
Correction to: Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA)
doi : 10.1093/rheumatology/kead004
Rheumatology, Volume 62, Issue 5, May 2023, Page 2022
The clinical impact of systemic sclerosis-related calcinosis—results of a patient survey
Emma Pearson, Emma Blamont, Sarah Wilkinson, Ariane L Herrick
doi : 10.1093/rheumatology/keac538
Rheumatology, Volume 62, Issue 5, May 2023, Pages e140–e141
Specialist nurse training in ultrasonography for the diagnosis of giant cell arteritis
Georgina Ducker, Chetan B Mukhtyar
doi : 10.1093/rheumatology/keac591
Rheumatology, Volume 62, Issue 5, May 2023, Pages e142–e143
SNP-based heritability estimates of gout and its subtypes determined by genome-wide association studies of clinically defined gout
Yu Toyoda, Masahiro Nakatochi, Akiyoshi Nakayama, Yusuke Kawamura, Hirofumi Nakaoka, Kenji Wakai, Keitaro Matsuo, Hirotaka Matsuo, for the Japan Gout Genomics Consortium
doi : 10.1093/rheumatology/keac597
Rheumatology, Volume 62, Issue 5, May 2023, Pages e144–e146
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study
Mrinalini Dey, Naveen R, Elena Nikiphorou, Parikshit Sen, Sreoshy Saha, James B Lilleker, Vishwesh Agarwal, Sinan Kardes, Jessica Day, Marcin Milchert, Mrudula Joshi, Tamer Gheita, Babur Salim, Tsvetelina Velikova, Abraham Edgar Gracia-Ramos, Ioannis Parodis, Albert Selva O’Callaghan, Minchul Kim, Tulika Chatterjee, Ai Lyn Tan, Ashima Makol, Arvind Nune, Lorenzo Cavagna, Miguel A Saavedra, Samuel Katsuyuki Shinjo, Nelly Ziade, Johannes Knitza, Masataka Kuwana, Oliver Distler, Bhupen Barman, Yogesh Preet Singh, Rajiv Ranjan, Avinash Jain, Sapan C Pandya, Rakesh Kumar Pilania, Aman Sharma, Manesh M Manoj, Vikas Gupta, Chengappa G Kavadichanda, Pradeepta Sekhar Patro, Sajal Ajmani, Sanat Phatak, Rudra Prosad Goswami, Abhra Chandra Chowdhury, Ashish Jacob Mathew, Padnamabha Shenoy, Ajay Asranna, Keerthi Talari Bommakanti, Anuj Shukla, Arunkumar R Pande, Kunal Chandwar, John D Pauling, Chris Wincup, Döndü Ãœsküdar Cansu, Erick Adrian Zamora Tehozol, Jorge Rojas Serrano, Ignacio GarcÃa-De La Torre, Nicoletta Del Papa, Gianluca Sambataro, Atzeni Fabiola, Marcello Govoni, Simone Parisi, Elena Bartoloni Bocci, Gian Domenico Sebastiani, Enrico Fusaro, Marco Sebastiani, Luca Quartuccio, Franco Franceschini, Pier Paolo Sainaghi, Giovanni Orsolini, Rossella De Angelis, Maria Giovanna Danielli, Vincenzo Venerito, Lisa S Traboco, Leonardo Santos Hoff, Suryo Anggoro Kusumo Wibowo, Stylianos Tomaras, Daman Langguth, Vidya Limaye, Merrilee Needham, Nilesh Srivastav, Akira Yoshida, Ran Nakashima, Shinji Sato, Naoki Kimura, Yuko Kaneko, Jesús Loarce-Martos, Sergio Prieto-González, Albert Gil-Vila, Raquel Arà nega Gonzalez, Hector Chinoy, Vikas Agarwal, Rohit Aggarwal, Latika Gupta, COVAD Study Group
doi : 10.1093/rheumatology/keac603
Rheumatology, Volume 62, Issue 5, May 2023, Pages e147–e152
Smartphone images of digital ulcers provide a clear picture of disease progression for the first rheumatology visit
Anastasia-Vasiliki Madenidou, Graham Dinsdale, Muditha Samaranayaka, Lindsay Muir, William G Dixon, Ariane L Herrick
doi : 10.1093/rheumatology/keac561
Rheumatology, Volume 62, Issue 5, May 2023, Pages e153–e154
A new autoantibody to valyl transfer RNA synthetase associated with anti-synthetase syndrome
Tsuneo Sasai, Ran Nakashima, Mirei Shirakashi, Ryosuke Hiwa, Hideaki Tsuji, Koji Kitagori, Shuji Akizuki, Hajime Yoshifuji, Tsuneyo Mimori, Akio Morinobu
doi : 10.1093/rheumatology/keac569
Rheumatology, Volume 62, Issue 5, May 2023, Pages e155–e157
Monkeypox in a patient with undifferentiated connective tissue disease
Tommaso Clemente, Diana Canetti, Lorenzo Dagna, Caterina Uberti Foppa, Antonella Castagna, Vincenzo Spagnuolo, Silvia Nozza, Corrado Campochiaro
doi : 10.1093/rheumatology/keac568
Rheumatology, Volume 62, Issue 5, May 2023, Pages e158–e160
Guillain–Barré syndrome is associated with ixekizumab in a patient with pustular psoriasis
Haijun Liu, Qianhua Li, Qingfeng Li, Xia Li, Lie Dai
doi : 10.1093/rheumatology/keac609
Rheumatology, Volume 62, Issue 5, May 2023, Pages e161–e163,
Comment on: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding
Karen Schreiber, Margreta Frishman, Beverley J Hunt
doi : 10.1093/rheumatology/keac700
Rheumatology, Volume 62, Issue 5, May 2023, Pages e164–e165
Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3
Lieselotte Vande Walle, Mohamed Lamkanfi
doi : 10.1093/rheumatology/keac717
Rheumatology, Volume 62, Issue 5, May 2023, Pages e166–e167
Comment on: Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3: Reply
Alexander N R Weber, Ana Tapia-Abellán, Xiao Liu, Juan I Aróstegui, Pablo PelegrÃn, Tatjana Welzel, Jasmin B Kuemmerle-Deschner
doi : 10.1093/rheumatology/keac718
Rheumatology, Volume 62, Issue 5, May 2023, Pages e168–e169
An unusual presentation of cutaneous lupus erythematosus as a unilateral periorbital erythematous-to-violaceous oedematous plaque
Yexiao Wang, Chaocheng Liu, Hui Zhou
doi : 10.1093/rheumatology/keac514
Rheumatology, Volume 62, Issue 5, May 2023, Pages e170–e171
Text neck misdiagnosed as fibromyalgia
Taro Horino, Hiroshi Ohnishi, Masahiro Komori, Yoshio Terada
doi : 10.1093/rheumatology/keac571
Rheumatology, Volume 62, Issue 5, May 2023, Pages e172–e173
Scalp necrosis during a giant cell arteritis relapse triggered by a VZV infection
Thibaud Chazal, Gaelle Clavel
doi : 10.1093/rheumatology/keac570
Rheumatology, Volume 62, Issue 5, May 2023, Page e174
